Gefitinib in patients with non-small cell lung cancer: symptomatic improvement within a few days.

Bearz, A

Gefitinib in patients with non-small cell lung cancer: symptomatic improvement within a few days. [electronic resource] - Lung cancer (Amsterdam, Netherlands) Sep 2005 - 417-8 p. digital

Publication Type: Letter

0169-5002

10.1016/j.lungcan.2005.03.027 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Agents--therapeutic use
Carcinoma, Non-Small-Cell Lung--drug therapy
Clinical Trials as Topic
Disease Progression
Female
Gefitinib
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged
Quinazolines--therapeutic use
Salvage Therapy
Time Factors
Treatment Outcome